Pharsight

Flawless generic launch strategy to prevent delays

With Pharsight, monitor all factors influencing your generic drug launch

Most Popular Collections

Top 10 Blockbuster Drug Patents Expiring in 2025

Drugs with Orange Book Exclusivities Expiring in 2025

Top 50 Drugs with Expiring Patents and Litigation Opportunities

Cancer Drug Patents

Drugs Opening to Patent Challenges in 2025

Drugs with Only 1 Patent Left for Expiry

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.
Get the exclusive patent insights now. Don't be the last to know.

Our insights are consumed by 1000+ leading pharma companies

How does Pharsight help?

See which drugs and companies are entering and exiting the market by monitoring new drug launches and patent expirations.

Pinpoint the openings to challenge weak patents and be the first to file generics by tracking drug patent litigations, EP oppositions, family trees, and para IV filings.

Search any drug and discover companies who have already filed for its generic to stay ahead in making informed decisions on partnerships, investments, and competitive strategies.

Get access to exclusive reports on collaboration opportunities, blockbuster drug patent expiration, and other strategic developments shaping the pharmaceutical landscape.

Explore data-driven insights on top drugs with patents ripe for challenge, based on a comprehensive analysis of legal and quantitative factors.

Have Questions?